# OnCo record conko-005 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/conko-005/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "conko-005" ;
  schema:name "CONKO-005"@en ;
  schema:alternateName "CONKO 005"@en ;
  schema:description "CONKO-005 was the first adjuvant trial to add a targeted drug to chemotherapy after pancreatic surgery; six months of erlotinib with gemcitabine made no difference to the time before relapse (11.4 months in both arms) or to survival."@en ;
  schema:url <https://onco.cc/trials/conko-005/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2017.72.6463>, <https://doi.org/10.1097/COC.0000000000000633> ;
  onco:status "negative" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/erlotinib/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:institutions <https://onco.cc/institutions/charite/> ;
  onco:terms <https://onco.cc/terms/pancreatic-failed-programmes/> .